Skip to main content

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

    • Advances in Pharmacology

      • 1st Edition
      • Volume 46
      • May 5, 1999
      • English
      • Paperback
        9 7 8 0 1 2 3 9 1 7 6 0 7
      • Hardback
        9 7 8 0 1 2 0 3 2 9 4 7 2
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 8 5
      Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.
    • Cumulative Subject Index

      • 1st Edition
      • Volume 45
      • October 16, 1998
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 4 6 5
      • Paperback
        9 7 8 0 1 2 3 9 1 7 5 9 1
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 7 8
      Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental. For easy reference, this volume provides a cumulative subject index covering Volumes 25-44.
    • Annual Reports in Medicinal Chemistry

      • 1st Edition
      • Volume 33
      • August 11, 1998
      • James A. Bristol + 5 more
      • English
      • Paperback
        9 7 8 0 1 2 0 4 0 5 3 3 6
      • eBook
        9 7 8 0 0 8 0 5 8 3 7 7 8
      Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expectedto provide the basis for entirely new future therapies.
    • Progress in Medicinal Chemistry

      • 1st Edition
      • Volume 35
      • July 3, 1998
      • English
      • Hardback
        9 7 8 0 4 4 4 8 2 9 0 9 2
      • Paperback
        9 7 8 0 4 4 4 5 4 8 0 1 6
      • eBook
        9 7 8 0 0 8 0 8 6 2 8 3 5
      Eminent scientists at the cutting edge of pharmacology and medicinal chemistry research provide us with yet another excellent addition to this famous series. The focus on bacterial resistance mechanisms serves to highlight an important area of unmet medical need requiring the attention of medicinal chemists. Five topical subjects are reviewed: the biosynthesis, metabolism and function of Vitamin D3 and the potential application of its analogues in bone disorders and immune-related diseases; the therapeutic potential of neurokinin antagonists; opioid receptor antagonists; the mechanisms of bacterial resistance; and a survey of recent advances in cannabinoid research. This volume will deservedly take its place in clinical and industrial pharmaceutical libraries, and will prove invaluable to medicinal chemists.
    • Asthma

      • 3rd Edition
      • April 20, 1998
      • Peter J. Barnes + 2 more
      • English
      • Hardback
        9 7 8 0 1 2 0 7 9 0 2 7 2
      • eBook
        9 7 8 0 0 8 0 5 2 5 5 2 5
      Now available in its Third Edition, Asthma: Basic Mechanisms and Clinical Management has become the reference text in asthma. This highly successful text sheds new light on the basic physiological and molecular mechanisms of asthma, how current treatments work, and how best to apply the latest knowledge to control this important disease. The Third Edition has undergone radical revision and includes several new chapters. It retains the virtues of the previous volumes by bringing together all of the recent research findings by internationally recognized experts on the causative mechanisms of asthma, including in-depth clinical aspects and therapy. The book presents an integrated approach toward the treatment of this disease with new concepts, changes in asthma management, and the development of new therapeutic agents. Asthma provides extensive references for researchers and clinicians who need to keep abreast of recent developments in this rapidly expanding field.
    • Stable Isotopes in Pharmaceutical Research

      • 1st Edition
      • Volume 26
      • December 18, 1997
      • T.R. Browne
      • English
      • Hardback
        9 7 8 0 4 4 4 8 1 9 4 1 3
      • eBook
        9 7 8 0 0 8 0 5 4 1 6 7 9
      Stable isotope techniques offer advantages in safety, sensitivity, specificity, and economy for many types of pharmaceutical investigations when compared to conventional techniques. Nevertheless, pharmaceutical researchers are slow to embrace stable isotope techniques.This book assembles in one place comprehensive reviews of the many applications of stable isotopes and the background material necessary to understand the application. This approach is a deliberate attempt to encourage the usage of stable isotopes in pharmaceutical research. A bonus to the reader is the high standard of contributions from a very talented and diverse group of investigators.
    • A Manual of Adverse Drug Interactions

      • 5th Edition
      • November 17, 1997
      • J.P. Griffin + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 4 8 2 4 0 6 6
      • Paperback
        9 7 8 0 4 4 4 5 4 6 1 8 0
      • eBook
        9 7 8 0 0 8 0 5 2 5 8 3 9
      For twenty years this book, now in its 5th edition, has provided information on adverse drug interactions that is unrivalled in coverage and scholarship.Adverse drug reactions, many of them ascribable to interactions with other drugs or with chemical substances in food or the environment, are thought to cause or complicate one in twenty of hospital admissions.The book is conveniently divided into two parts: Part 1 comments on drug interactions and their mechanisms, on a pharmacokinetic and pharmacodynamic level, while Part 2 consists of drug interaction tables, divided and subdivided into categories of disorders, and the drugs used in the treatment of these disorders.If safety in drugs is to improve, education of prescribers is vitally important. This book, with its up-to-date and coordinated approach, serves that purpose well. The real threat, as the authors remind us, is the ignorance of practitioners, not the drug itself. The volume is therefore an essential addition to the shelves of those responsible for the prescription of drugs, in order to prevent a potential backlash when used in combination with other drugs or chemical substances.
    • Advances in Cancer Research

      • 1st Edition
      • Volume 73
      • October 20, 1997
      • English
      • Paperback
        9 7 8 0 1 2 3 9 9 3 1 5 1
      • Hardback
        9 7 8 0 1 2 0 0 6 6 7 3 5
      • eBook
        9 7 8 0 0 8 0 5 6 2 5 5 1
      Academic Press proudly presents this Cumulative Subject Index covering Volumes 50-72 of Advances in Cancer Research. In one comprehensive source, the interested reader can find references to specific articles on topics such as breast cancer, prostate cancer, Kaposi's sarcoma, Burkitt's lymphoma, leukemias, oncogenes, transcription factors, tumor genetics, p53, T-cell receptors, and drug resistance. This cumulative index will serve not only as a complete overview of the major topics published in Advances in Cancer Research, but also as an indicator of the progress made in cancer research over the last ten years.
    • Catecholamines: Bridging Basic Science with Clinical Medicine

      • 1st Edition
      • Volume 42
      • October 20, 1997
      • English
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 4 7
      This volume in Advances in Pharmacology focuses on all aspects of catecholamine research, from very basic to medical. It is broad based and covers many areas within physiology and medicine.
    • Drug-Drug Interactions: Scientific and Regulatory Perspectives

      • 1st Edition
      • Volume 43
      • October 2, 1997
      • English
      • Hardback
        9 7 8 0 1 2 0 3 2 9 4 4 1
      • eBook
        9 7 8 0 0 8 0 5 8 1 3 5 4
      Drug–Drug Interactions is a comprehensive review of the scientific and regulatory perspectives of drug–drug interactions from the point-of-view of academia, industry, and government regulatory agencies. This book is intended for professionals in the pharmaceutical industry, health care, and governmental regulatory agencies. Topics of interest include the mechanistic understanding of drug–drug interactions, the prediction of drug–drug interaction potential of new drugs, and the avoidance of clinically significant drug–drug interaction in patients.